Ramiro Ribeiro
Vermögen: - $ am 31.05.2026
Vermögen: - $ am 31.05.2026
Ramiro Ribeiro is currently Chief Medical Officer at EyePoint, Inc. since 2024.
Formerly, Dr. Ribeiro was Vice President & Head-Clinical Development at Apellis Pharmaceuticals, Inc. from 2018 to 2024.
Education includes doctorates from Universidade Federal De Sao Paulo and Pontificia Universidade Catolica Do Parana.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EYEPOINT, INC. -.--% | 21.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| EYEPOINT, INC. | Technik-/Wissenschafts-/F&E-Leiter | 04.03.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.03.2024 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
Pontificia Universidade Catolica Do Parana
Pontificia Universidade Catolica Do Parana Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universidade Federal De Sao Paulo
Universidade Federal De Sao Paulo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen